Lttl vs MEDGm

Choose Lttl if…

• +About $2,301 a year less than MEDGm for compounded semaglutide at standing prices (one bills every 4 weeks (13 charges a year), so this compares modeled yearly cost)
• +Accepts FSA/HSA cards
• +Publishes the full price matrix — every medication, form and commitment length — on a public /plans page before checkout

What to weigh up

• −No published state list; confirm yours at signup
• −Partner pharmacies are never named — the site refers only to 'a partner U.S. pharmacy' (a material disclosure gap for a YMYL purchase)
• −Headline 'Plans start at' prices ($89 semaglutide, $139 tirzepatide) are 12-month prepay rates; month-to-month is $99 and $149

Choose MEDGm if…

• +Publishes its full state list (50 states + DC)
• +Names the molecule on every compounded product page and prints the full 3-, 6- and 12-month price ladder publicly
• +Every product page states 'Same price, any dose', so titrating up does not raise the bill

What to weigh up

• −About $2,301 a year more than Lttl for compounded semaglutide (one bills every 4 weeks (13 charges a year), so this compares modeled yearly cost)
• −No dose ladder is published — the site never says which milligram strength you start on or how it steps up
• −You pay before a clinician reviews you — the Terms say the consult happens after the fee is charged